Related Experiment Video
Updated: Jan 29, 2026

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
Published on: November 7, 2015
Peptide Arrays as Tools for Unraveling Tumor Microenvironments and Drug Discovery in Oncology
Anna Grab1, Christoph Reißfelder1, Alexander Nesterov-Mueller2
1Department of Surgery, Mannheim Medical Center, Ruprecht-Karls-University Heidelberg, 68167 Mannheim, Germany.
Abstract:
Peptide arrays represent a powerful tool for investigating a wide application field for biomedical questions. This review summarizes recent applications of peptide chips in oncology, with a focus on tumor microenvironment, metastasis, and drug mechanism of action for various cancer types. These high-throughput platforms enable the simultaneous screening of thousands of peptides. We report on recent achievements in peptide array technology for tumor microenvironments, an enhanced ability to decipher complex cancer-related signaling pathways, and characterization of cell-adhesion-mediating peptides. Furthermore, we highlight the applications in high-throughput drug screenings for development of immune therapies, e.g., the development of novel neoantigen therapies of glioblastoma. Moreover, epigenetic profiling using peptide arrays has uncovered new therapeutic targets across various cancer types with clinical impact. In conclusion, we discuss artificial intelligence-driven peptide array analysis as a tool to determine tumor origin and metastatic state, potentially transforming diagnostic approaches. These innovations promise to accelerate the development of precision cancer approaches.
Insights
Peptide arrays offer high-throughput screening for cancer research, aiding in understanding tumor microenvironments, metastasis, and drug actions. This technology accelerates precision oncology by identifying new therapeutic targets and diagnostic tools.
Area of Science:
- Biomedical research
- Oncology
- Peptide array technology
Background:
- Peptide arrays are versatile tools for biomedical research.
- Recent advancements have expanded their application in oncology.
Purpose of the Study:
- To review recent applications of peptide chips in oncology.
- Focusing on tumor microenvironment, metastasis, and drug mechanisms.
- Highlighting advancements in high-throughput screening and diagnostics.
Main Methods:
- High-throughput screening of thousands of peptides simultaneously.
- Utilizing peptide array technology for epigenetic profiling.
- Applying artificial intelligence for data analysis.
Main Results:
- Characterization of cell-adhesion peptides and signaling pathways.
- Identification of novel therapeutic targets across various cancer types.
- Development of immune therapies, including neoantigen therapies for glioblastoma.
Conclusions:
- Peptide arrays enhance understanding of tumor microenvironments and metastasis.
- They facilitate high-throughput drug screening and epigenetic profiling.
- AI-driven analysis of peptide arrays shows potential for transforming cancer diagnostics and precision medicine.
Related Concept Videos
The Tumor Microenvironment
Drug Discovery: Overview
Peptide Bonds
Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
Overview of Microsoft Excel as a Data Analysis Tool
Pharmacokinetics: Drug–Drug Interactions

